137 related articles for article (PubMed ID: 26504360)
41. Gout as a risk factor for osteoporosis: response to comments by Kostev.
Kok VC
Osteoporos Int; 2018 Jul; 29(7):1687. PubMed ID: 29637220
[No Abstract] [Full Text] [Related]
42. Carbon dioxide combining power in thyrotoxicosis, cancer and gout.
ALTER SM
Ann West Med Surg; 1948 Feb; 2(2):88. PubMed ID: 18904091
[No Abstract] [Full Text] [Related]
43. Among the Company That Gout Keeps, Is Cancer on the List?
Gelber AC
J Rheumatol; 2021 Sep; 48(9):1358-1360. PubMed ID: 33993111
[No Abstract] [Full Text] [Related]
44. Meta-analysis confirms an association between gout and a common variant of LRRC16A locus.
Ogata H; Matsuo H; Sakiyama M; Higashino T; Kawaguchi M; Nakayama A; Naito M; Ooyama H; Ichida K; Shinomiya N
Mod Rheumatol; 2017 May; 27(3):553-555. PubMed ID: 27585540
[No Abstract] [Full Text] [Related]
45. Correction to: Coagulation in gout: is there a link with disease activity?
Vedder D; Gerritsen M; Meijers JCM; Nurmohamed MT
Clin Rheumatol; 2022 Jun; 41(6):1937-1938. PubMed ID: 35244785
[No Abstract] [Full Text] [Related]
46. Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis.
Liu R; Han C; Wu D; Xia X; Gu J; Guan H; Shan Z; Teng W
Biomed Res Int; 2015; 2015():762820. PubMed ID: 26640795
[TBL] [Abstract][Full Text] [Related]
47. Hyperuricemia and gout are associated with cancer incidence and mortality: A meta-analysis based on cohort studies.
Xie Y; Xu P; Liu K; Lin S; Wang M; Tian T; Dai C; Deng Y; Li N; Hao Q; Zhou L; Dai Z; Guo H
J Cell Physiol; 2019 Aug; 234(8):14364-14376. PubMed ID: 30693505
[TBL] [Abstract][Full Text] [Related]
48. Serum Uric Acid Increases Risk of Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis.
Yan S; Zhang P; Xu W; Liu Y; Wang B; Jiang T; Hua C; Wang X; Xu D; Sun B
Mediators Inflamm; 2015; 2015():764250. PubMed ID: 26504361
[TBL] [Abstract][Full Text] [Related]
49. Friend or Foe? An Unrecognized Role of Uric Acid in Cancer Development and the Potential Anticancer Effects of Uric Acid-lowering Drugs.
Mi S; Gong L; Sui Z
J Cancer; 2020; 11(17):5236-5244. PubMed ID: 32742469
[TBL] [Abstract][Full Text] [Related]
50. Hyperuricemia and Cardiovascular Disease.
Zhang S; Wang Y; Cheng J; Huangfu N; Zhao R; Xu Z; Zhang F; Zheng W; Zhang D
Curr Pharm Des; 2019; 25(6):700-709. PubMed ID: 30961478
[TBL] [Abstract][Full Text] [Related]
51. Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase.
Battelli MG; Bortolotti M; Polito L; Bolognesi A
Redox Biol; 2019 Feb; 21():101070. PubMed ID: 30576922
[TBL] [Abstract][Full Text] [Related]
52. Cancer risk in Korean patients with gout.
Oh YJ; Lee YJ; Lee E; Park B; Kwon JW; Heo J; Moon KW
Korean J Intern Med; 2022 Mar; 37(2):460-467. PubMed ID: 32872748
[TBL] [Abstract][Full Text] [Related]
53. Cross-phenotype association analysis of gastric cancer: in-silico functional annotation based on the disease-gene network.
Lee S; Yang HK; Lee HJ; Park DJ; Kong SH; Park SK
Gastric Cancer; 2023 Jul; 26(4):517-527. PubMed ID: 36995485
[TBL] [Abstract][Full Text] [Related]
54. The effect of colchicine on cancer risk in patients with immune-mediated inflammatory diseases: a time-dependent study based on the Taiwan's National Health Insurance Research Database.
Yeh JJ; Liw PX; Wong YS; Kao HM; Lee CH; Lin CL; Kao CH
Eur J Med Res; 2024 Apr; 29(1):245. PubMed ID: 38649928
[TBL] [Abstract][Full Text] [Related]
55. Longitudinal changes in high sensitivity C-reactive protein associated with serum uric acid in the Korean Genome and Epidemiology Study.
Kityo A; Lee SA
Sci Rep; 2024 Jan; 14(1):374. PubMed ID: 38172510
[TBL] [Abstract][Full Text] [Related]
56. Gout and Colorectal Cancer Likelihood: Insights from a Nested Case-Control Study of the Korean Population Utilizing the Korean National Health Insurance Service-National Sample Cohort.
Kwon MJ; Han KM; Kim JH; Kim JH; Kim MJ; Kim NY; Choi HG; Kang HS
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067309
[TBL] [Abstract][Full Text] [Related]
57. Association between gout and subsequent breast cancer: a retrospective cohort study including 67,598 primary care patients in Germany.
Gremke N; Griewing S; Kostev K; Wagner U; Kalder M
Breast Cancer Res Treat; 2023 Jun; 199(3):545-552. PubMed ID: 37071268
[TBL] [Abstract][Full Text] [Related]
58. The Good, the Bad and the New about Uric Acid in Cancer.
Allegrini S; Garcia-Gil M; Pesi R; Camici M; Tozzi MG
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230882
[TBL] [Abstract][Full Text] [Related]
59. Systematic Review of the Role of Alpha-Protein Kinase 1 in Cancer and Cancer-Related Inflammatory Diseases.
Ko AM; Tu HP; Ko YC
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139553
[TBL] [Abstract][Full Text] [Related]
60. Baseline serum uric acid level is associated with progression-free survival, disease control rate, and safety in postoperative patients with colorectal cancer treated by FOLFOX, FOLFIRI, or XELOX.
Zhang X; Chen QH; Yang Y; Lin JX; Li YC; Zhong TY; Chen J; Wu SQ; Chen XH; Zhou RS; Lin JM; Wang DQ; He QX; You YT; Zhou XH; Zuo Q; Liu YY; Cheng JR; Wu YF; Zhao XS
Front Oncol; 2022; 12():918088. PubMed ID: 35965512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
